Federal Trade Commission to Investigate Deception, Fraud in Transgender Industry

Doctors who pitched irreversible surgeries and sterilizing hormone regimens to minors struggling with gender dysphoria may have illegally deceived patients and their parents, according to Federal Trade Commission Chairman Andrew Ferguson.

The statute that created the Federal Trade Commission authorizes it to prevent “unfair or deceptive” practices affecting consumers. The FTC hosted a daylong workshop called “The Dangers of Gender-Affirming Care for Minors” to hear from stakeholders and determine if the transgender industry has deceived families.

Informed by the findings of the workshop, the FTC will issue a public request for information on transgender medical interventions next week.

Read more on the Daily Signal.